Abstract
Inflammatory and infectious diseases include many different clinical conditions not often well recognised and characterized with conventional radiology and biochemical tests. Radiological techniques (TC, MRI, US) show anatomical changes that usually occur in chronic stages of the disease leading to a delayed diagnosis and therapy. The possibility of Nuclear Medicine imaging to detect biological and biochemical changes in the earliest phases of diseases, allow the clinician not only to promptly identify the infective or inflammatory focus, but also to establish the best therapeutic approach for the patient. The recent availability of different monoclonal antibodies and analogues of growth and signalling factors offers physicians a wide spectrum of promising radiopharmaceuticals as markers for different pathological events. Therefore, NM may help in therapy decision making, management and follow-up through the evaluation of the expression of these specific molecules, leading to the development of personalized therapies. The appeal to Nuclear Medicine imaging is becoming, indeed, more and more widespread not only for diagnostic purposes, but also for monitoring drug efficacy. Several advances have been observed in this field, and they seem to be very promising for a tailored medicine.
Keywords: Infection, inflammation, radiolabelled cells, radiolabelled antibodies, radiolabelled antibiotics, FDG.
Current Pharmaceutical Design
Title:Radiolabelled Probes Targeting Infection and Inflammation for Personalized Medicine
Volume: 20 Issue: 14
Author(s): Alberto Signore, Chiara Lauri and Filippo Galli
Affiliation:
Keywords: Infection, inflammation, radiolabelled cells, radiolabelled antibodies, radiolabelled antibiotics, FDG.
Abstract: Inflammatory and infectious diseases include many different clinical conditions not often well recognised and characterized with conventional radiology and biochemical tests. Radiological techniques (TC, MRI, US) show anatomical changes that usually occur in chronic stages of the disease leading to a delayed diagnosis and therapy. The possibility of Nuclear Medicine imaging to detect biological and biochemical changes in the earliest phases of diseases, allow the clinician not only to promptly identify the infective or inflammatory focus, but also to establish the best therapeutic approach for the patient. The recent availability of different monoclonal antibodies and analogues of growth and signalling factors offers physicians a wide spectrum of promising radiopharmaceuticals as markers for different pathological events. Therefore, NM may help in therapy decision making, management and follow-up through the evaluation of the expression of these specific molecules, leading to the development of personalized therapies. The appeal to Nuclear Medicine imaging is becoming, indeed, more and more widespread not only for diagnostic purposes, but also for monitoring drug efficacy. Several advances have been observed in this field, and they seem to be very promising for a tailored medicine.
Export Options
About this article
Cite this article as:
Signore Alberto, Lauri Chiara and Galli Filippo, Radiolabelled Probes Targeting Infection and Inflammation for Personalized Medicine, Current Pharmaceutical Design 2014; 20 (14) . https://dx.doi.org/10.2174/13816128113196660666
DOI https://dx.doi.org/10.2174/13816128113196660666 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances in Treatment Approaches of Mucopolysaccharidosis VI
Current Pharmaceutical Biotechnology Coarctation of the Aorta - An Evolution of Therapeutic Options
Current Cardiology Reviews Ischemic Strokes in Congenital Bleeding Disorders: Comparison with Myocardial Infarction and other Acute Coronary Syndromes
Cardiovascular & Hematological Disorders-Drug Targets Acethylcholinesterase Inhibition, Antibacterial and Antioxidant Properties of Diaryl Oxalates
Current Enzyme Inhibition Prevalence of Dilated Cardiomyopathy in HIV-Infected African Patients Not Receiving HAART: A Multicenter, Observational, Prospective, Cohort Study in Rwanda
Current HIV Research A Brief Overview of Antimicrobial Peptides Containing Unnatural Amino Acids and Ligand-Based Approaches for Peptide Ligands
Current Topics in Medicinal Chemistry Cardiac Tumors: Clinical Perspective and Therapeutic Considerations
Current Drug Targets Imidazole Derivatives and their Antibacterial Activity - A Mini-Review
Mini-Reviews in Medicinal Chemistry The Deadly Quartet (Covid-19, Old Age, Lung Disease, and Heart Failure) Explains Why Coronavirus-Related Mortality in Northern Italy Was So High
Current Cardiology Reviews γ-Secretase Inhibitors and Modulators for the Treatment of Alzheimer's Disease: Disappointments and Hopes
Current Topics in Medicinal Chemistry Single Photon Emission Tomography in the Diagnostic Assessment of Cardiac and Vascular Infectious Diseases
Current Radiopharmaceuticals Waste Material of Propolis as a Film Forming Agent Intended to Modify the Metronidazole Release: Preparation and Characterization
Current Drug Delivery Mass Spectrometry-Based Approaches for the Detection of Proteins of Staphylococcus Species
Infectious Disorders - Drug Targets High-Level Aminoglycoside Resistance in Enterococcus Faecalis and Enterococcus Faecium; as a Serious Threat in Hospitals
Infectious Disorders - Drug Targets Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review
Current Cardiology Reviews HtrA Protease Family as Therapeutic Targets
Current Pharmaceutical Design Systemic Fungal Infections Caused by Candida Species: Epidemiology, Infection Process and Virulence Attributes
Current Drug Targets Vasopressin and Terlipressin in Neonates and Children with Refractory Septic Shock
Current Drug Metabolism Drug-Induced Thromboembolic Events in Patients with Malignancy
Cardiovascular & Hematological Disorders-Drug Targets Short Term Statin Treatment Improves Survival and Differentially Regulates Macrophage-Mediated Responses to Staphylococcus aureus
Current Pharmaceutical Biotechnology